logo-loader
viewFaron Pharmaceuticals Ltd

analyst interview 1

analyst interview 1 analyst interview 1 analyst interview 1

analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1 analyst interview 1

Quick facts: Faron Pharmaceuticals Ltd

Price: - -

AIM:FARN
Market: AIM
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Faron Pharmaceuticals Ltd named herein, including the promotion by the Company of Faron Pharmaceuticals Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: ImmuPharma lands licensing deal for Lupuzor

Headlines from the Proactive UK newsroom. ImmuPharma (LON:IMM) has signed an exclusive licence and development agreement with Avion Pharmaceuticals for its Lupus treatment Lupuzor.  Avion will fund a new international Phase III trial up to a cost of US$25mln and commercialise the...

on 28/11/19

2 min read